Steve Forte
EVP, CHIEF FINANCIAL OFFICER · Repare Therapeutics Inc.
Individual
- 2026
- Jan 29, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Steve Forte's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- Paul R. Vigano - $371.84M in AVAH purchases and sales in the last 12 months
- Robert M. Williams Jr. - $371.84M in AVAH purchases and sales in the last 12 months
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M in AVAH purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steve Forte?
Steve Forte is a corporate insider, tracked as EVP, CHIEF FINANCIAL OFFICER of Repare Therapeutics Inc. (RPTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Steve Forte last file a Form 4?
The only primary Form 4 on record is dated 29 January 2026.
